WGS logo

GeneDx Holdings Corp. Class A Common Stock


WGS: GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx and Legacy Sema4 diagnostics.


Show WGS Financials

Consumer Interest
SEC Filings

Recent trades of WGS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by WGS's directors and management

Government lobbying spending instances

  • $17,500 May 15, 2023 Issue: Medical/Disease Research/Clinical Labs
  • $17,500 Oct 17, 2022 Issue: Medical/Disease Research/Clinical Labs
  • $35,000 Apr 20, 2022 Issue: Medical/Disease Research/Clinical Labs
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard

Number of mentions of WGS in WallStreetBets Daily Discussion

WGS News

Recent insights relating to WGS

CNBC Recommendations

Recent picks made for WGS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in WGS

Corporate Flights

Flights by private jets registered to WGS